Pharmacokinetics
Abstract
Pharmacokinetics (PK) is the study of the time course of the absorption, distribution, metabolism and excretion (ADME) of a drug, compound or new chemical entity (NCE) after its administration to the body. Following a brief introduction as to why knowledge of the PK properties of an NCE is critical to its selection as a lead candidate in a drug discovery program and/or its use as a functional research tool, the present article presents an overview of PK principles, including practical guidelines for conducting PK studies as well as the equations required for characterizing and understanding the PK of an NCE and its metabolite(s). A review of the determination of in vivo PK parameters by non-compartmental and compartmental methods is followed by a brief overview of allometric scaling. Compound absorption and permeability are discussed in the context of intestinal absorption and brain penetration. The volume of distribution and plasma protein and tissue binding are covered as is the clearance (systemic, hepatic, renal, biliary) of both small and large molecules. A section on metabolite kinetics describes how to estimate the PK parameters of a metabolite following administration of an NCE. Lastly, mathematical models used to describe pharmacodynamics (PD), the relationship between the NCE/compound concentration at the site of action and the resulting effect, are reviewed and linked to PK models in a section on PK/PD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The citation lists haven’t been fetched yet
References 153 · Cited by 309
- Authors
- Fan, J., & de Lannoy, I. A. M.
- ORCID
- Fan, Jianghong
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 87
- Issue
- 1
- Pages
- 93-120
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W4210952837
- Cited by
- 309
- References
- 153
- Citations by year
- 2026: 25 · 2025: 37 · 2024: 31 · 2023: 33 · 2022: 25 · 2021: 28 · 2020: 33 · 2019: 21 · 2018: 16 · 2017: 20 · 2016: 13 · 2015: 11 · 2014: 11 · 2013: 5
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- pharmacokinetics, ADME, new chemical entities, drug discovery, non-compartmental analysis, compartmental modeling, allometric scaling, intestinal absorption, brain penetration, volume of distribution, plasma protein binding, tissue binding, clearance, hepatic clearance, renal clearance, biliary excretion, metabolite kinetics, pharmacodynamics, pharmacokinetic-pharmacodynamic modeling
- MeSH terms
- Animals, Pharmaceutical Preparations, Half-Life, Humans, Intestinal Absorption, Metabolic Clearance Rate, Permeability, Tissue Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review